- This event has passed.
What Is the State-of-the-Art in Stem Cell?
September 24, 2019 @ 12:00 PM – 3:00 PM
Join us for an informal discussion over a light lunch about the current state of the Stem Cell/Regenerative Medicine Industry! We’ll cover emerging opportunities and challenges in this field and how the MD Stem Cell Research Fund has helped advance stem cell research, commercialization and cures. If you are in life sciences you will want to participate in this event.
The Maryland Stem Cell Research Fund (MSCRF) is focused on identifying and fostering cutting-edge research and innovation in the field of regenerative medicine in MD. Their Accelerating Cures initiative comprises programs that help transition human stem cell-based technologies from the bench to the bedside as well as mechanisms to build and grow stem cell companies in Maryland. MSCRF has invested over $155 million in accelerating stem cell research, cures and commercialization, in addition to building a collaborative stem cell community in our region. Learn more about their mission and funding opportunities at www.mscrf.org.
About the Speaker:
Dr. Jaishankar is the Associate Director of the MD Stem Cell Research Fund (MSCRF). In this role, Amritha is responsible for MSCRF business development, scientific management and oversight of portfolio ($156million, 460 projects to date). She works with stem cell scientists across Maryland to develop a collaborative research program and promote commercialization of stem cell technologies. Amritha brings over 14 years of experience in stem cell research and program management in federal, academic, and industry settings. She is passionate about using stem cell technologies to accelerate cures for patients in need.
This event is FREE. A light lunch will be served so kindly RSVP and update your RSVP should your plans change. Parking is FREE in the GIC parking lot.